跳至主要内容
临床试验/NCT02139384
NCT02139384撤回不适用

Development of a Clinical Pediatric Pneumonia Score in Critically Ill Children Admitted With Acute Respiratory Failure

Loma Linda University1 个研究点 分布在 1 个国家开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
1
主要终点
Can our proposed pneumonia score distinguish community acquired bacterial pneumonia from community acquired viral pneumonia

研究概览

简要总结

The purpose of the study is to create a clinical pneumonia tool that can be used to predict the cause of community-acquired pneumonia, which is a lung infection that began outside of the hospital in critically ill children therefore limiting unnecessary antibiotic use. The investigators will enroll critically ill children admitted with acute respiratory failure and suspected pneumonia. Each patient will receive a clinical pneumonia score blinded from culture and respiratory viral panel results. All care after samples obtained will be at the discretion of the PICU team. The investigators believe that our clinical pneumonia scale with procalcitonin will accurately designate viral from bacterial etiologies.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
1 Day 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • All intubated pediatric patients
  • Age 1 day to 21 years
  • Admitted to the LLUCH PICU with suspected pneumonia for the next 6 months
  • Have received antibiotics for less than 12 hours
  • Have been intubated for less than 24 hours
  • Patients must be English or Spanish speaking for consent purposes.

排除标准

  • Patients who have received antibiotics for greater than 12 hours
  • Patients who have been intubated for greater than 24 hours
  • Patients who are unable to tolerate non-bronchoscopic bronchoalveolar lavage

结局指标

主要结局

Can our proposed pneumonia score distinguish community acquired bacterial pneumonia from community acquired viral pneumonia

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Clinical Pediatric Pneumonia Score in Critically Ill... | 临床试验